The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Is It Time for Quotas to Achieve Racial and Ethnic Representation in Multiple Sclerosis Trials?
Open accessAbstract
DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The focus on oncology further narrowed the range [71–73].”
From Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review (2025) · cites this paper as [73]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Polman, C. H., O'Connor, P. W., Havrdová, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T., LUBLIN, F. D., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,433
(2007) · Choice Reviews Online · doi:10.5860/choice.44-5683 · Cited by 1,292
Challenging Assumptions About Minority Participation in US Clinical Research
Fisher, J. A., & Kalbaugh, C. A. (2011) · American Journal of Public Health · doi:10.2105/ajph.2011.300279 · Cited by 333
GELLER, S. E., Koch, A. R., Roesch, P., Filut, A., Hallgren, E., & Carnes, M. L. (2017) · Academic Medicine · doi:10.1097/acm.0000000000002027 · Cited by 319
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis
Cree, B., Khan, O., BOURDETTE, D. N., Goodin, D., Cohen, J. A., Marrie, R. A., Glidden, D. V., Weinstock‐Guttman, B., Reich, D., Patterson, N. J., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000145762.60562.5d · Cited by 302
Cunningham‐Erves, J., Mayo‐Gamble, T. L., Fair, A. M., Boyer, A. P., Joosten, Y. A., Vaughn, Y. C., Sherden, L., Luther, P., Miller, S. T., & Wilkins, C. H. (2016) · Journal of Community Health · doi:10.1007/s10900-016-0279-2 · Cited by 229
Coakley, M., Fadiran, E. O., Parrish, L. J., Griffith, R. A., Weiss, E., & Carter, C. (2012) · Journal of Women's Health · doi:10.1089/jwh.2012.3733 · Cited by 186
Race and ethnicity on MS presentation and disease course
Amezcua, L., & McCauley, J. L. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458519887328 · Cited by 137
Langer-Gould, A. M., Lucas, R. M., Xiang, A. H., Chen, L., Wu, J., Gonzalez, E., Haraszti, S., Smith, J. B., Quach, H., & Barcellos, L. F. (2018) · Nutrients · doi:10.3390/nu10030268 · Cited by 72
Burlew, A. K., Weekes, J. C., Montgomery, L., Feaster, D. J., Robbins, M. S., Rosa, C. L., Ruglass, L. M., Venner, K. L., & Wu, L.-T. T. (2011) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2011.596973 · Cited by 60
Research works printed but not linked: 1
- Robers, 2020, Multiple sclerosis treatment in racial and ethnic minorities, Pract Neurol., 49
Cited by
Goodson, N., Wicks, P. J., Morgan, J., Hashem, L., Callinan, S., & Reites, J. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00603-y · Cited by 153
Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkers
Berger, M., Browndyke, J. N., Cooter, M. L., Nobuhara, C. K., Reese, M. A., Acker, L., Bullock, W. M., Colin, B. J., Devinney, M. J., Moretti, E. W., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51499 · Cited by 44
Alarcón Garavito, G. A., Gilchrist, K., Ciurtin, C., Khanna, S., Chambers, P., McNally, N., Merivale, E., Carr, E., Yu, R., & Vindrola-Padros, C. (2025) · Trials · doi:10.1186/s13063-025-08769-y · Cited by 42
“The focus on oncology further narrowed the range [71–73].”
Women's Health in Multiple Sclerosis: A Scoping Review
Ross, L. A., Ng, H. S., O’Mahony, J., Amato, M. P., Cohen, J. A., Harnegie, M. P., Hellwig, K., Tintoré, M., Vukusic, S., & Marrie, R. A. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.812147 · Cited by 25
Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients
Telesford, K. M., Amezcua, L., Tardo, L. M., Horton, L. A., Lund, B. T., Reder, A. T., Vartanian, T. K., & Monson, N. L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1172993 · Cited by 16
Perceptions of people with multiple sclerosis on social determinants of health: Mixed methods
Mateen, F. J., & Hacker, C. T. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.105089 · Cited by 14
Self-citationTwenty-year trends in racial and ethnic enrollment in large diabetes randomized controlled trials
Zhang, J., Spall, H. G. C. V., Wang, Y., Thabane, L., Wang, R., & Li, G. (2022) · BMC Medicine · doi:10.1186/s12916-022-02501-2 · Cited by 12
Fakolade, A. O., Akbar, N., Mehelay, S., Phadke, S., Tang, M., Alqahtani, A., Pullattayil, A. K., & Busse, M. E. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104606 · Cited by 10
Long-term trajectories of ambulatory impairment in multiple sclerosis
Gunzler, D. D., Nadai, A. S. D., Miller, D. M., Ontaneda, D., & Briggs, F. B. S. (2023) · Multiple Sclerosis Journal · doi:10.1177/13524585231187521 · Cited by 9
Barrett, A. M., Olayinka-Amao, O., Ziemssen, T., Bharadia, T., Henke, C., & Kamudoni, P. (2024) · Neurology and Therapy · doi:10.1007/s40120-024-00584-y · Cited by 6
Briggs, F. B. S., Trapl, E., Mateen, F. J., Nadai, A. S. D., Conway, D. S., & Gunzler, D. D. (2024) · International Journal of MS Care · doi:10.7224/1537-2073.2023-004 · Cited by 6
Self-citationAbuaf, A. F., Javed, A., Bunting, S. R., Carroll, T., Reder, A. T., & Cipriani, V. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104523 · Cited by 6
Puttick, N., Vanderslott, S., & Tanner, R. (2023) · BMJ Public Health · doi:10.1136/bmjph-2023-000042 · Cited by 4
Pharmacokinetics/pharmacodynamics by race: Analysis of a peginterferon β-1a phase 1 study
Zhao, Y. Q., Mokliatchouk, O., Ramia, N. F., Naylor, M. L., & Butts, C. L. (2022) · Med · doi:10.1016/j.medj.2022.06.006 · Cited by 1
Zhang, J., Van Spall, H. G. C., Wang, Y., Thabane, L., Wang, R., & Li, G. (2022) · Figshare · doi:10.6084/m9.figshare.21128144
Metadata
- Authors
- Mateen, F. J.
- Affiliations
- Harvard University (US)
- Corresponding author
- Mateen, Farrah J.
- ORCID
- Mateen, Farrah J.
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2021-05-13
- Volume
- 12
- Pages
- 680912-680912
- ISSN
- 1664-2295 (ISSN-L)
- PMC
- PMC8155278
- OpenAlex
- W3162010102
- Cited by
- 15
- References
- 16
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 6 · 2022: 6
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Neurology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Social Sciences › Anthropology › Race, Genetics, and Society
- Keywords
- racial and ethnic representation, multiple sclerosis, clinical trials, underrepresented groups, diversity in clinical research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
